Abstract
Studies have shown the infection rate to be 3-6% after spinal cord stimulator implantation (1). Superficial skin infection is typically treated by antibiotics only, whereas deep infection is treated by explanting the device followed by antibiotics (2). Pain management is challenging in such cases because only 25% of the patient undergo reimplantation of the device (3).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
